Mycenax Biotech and RIN Ink Licensing Agreement for ADC Advancement#Taiwan#Taipei#ADC#Mycenax_Biotech#RIN_Institute
Mycenax Biotech and RIN Ink Licensing Agreement for ADC Advancement
Mycenax Biotech Inc. and Japan's RIN Institute have signed a licensing agreement to utilize RIN's proprietary linker technology for ADC development, enhancing therapeutic solutions.
third-news.com
October 31, 2025 at 7:08 AM
Mycenax Biotech and RIN Ink Licensing Agreement for ADC Advancement#Taiwan#Taipei#ADC#Mycenax_Biotech#RIN_Institute
Mycenax Biotech Partners with RIN Institute to Advance ADC Development with Innovative Linker Technology#Taiwan#Taipei#ADC_Development#Mycenax_Biotech#RIN_Institute
Mycenax Biotech Partners with RIN Institute to Advance ADC Development with Innovative Linker Technology
Mycenax Biotech has signed a licensing agreement with RIN Institute to utilize its proprietary linker technology. This partnership aims to accelerate ADC development and offers enhanced therapeutic solutions.
third-news.com
October 31, 2025 at 7:07 AM
Mycenax Biotech Partners with RIN Institute to Advance ADC Development with Innovative Linker Technology#Taiwan#Taipei#ADC_Development#Mycenax_Biotech#RIN_Institute
Mycenax and RIN Collaboration to Enhance ADC Development Through Innovative Licensing Deal#Taiwan#Taipei#ADC_technology#Mycenax#Rin
Mycenax and RIN Collaboration to Enhance ADC Development Through Innovative Licensing Deal
Mycenax Biotech Inc. and RIN Institute forge a licensing agreement to advance antibody-drug conjugate technology, enhancing global drug solutions.
third-news.com
October 31, 2025 at 7:06 AM
Mycenax and RIN Collaboration to Enhance ADC Development Through Innovative Licensing Deal#Taiwan#Taipei#ADC_technology#Mycenax#Rin
Mycenax Biotech Partners with RIN to Enhance ADC Development Using Advanced Linker Technology#Taiwan#Taipei#ADC_Development#Mycenax_Biotech#RIN_Institute
Mycenax Biotech Partners with RIN to Enhance ADC Development Using Advanced Linker Technology
Mycenax Biotech Inc. and Japan's RIN Institute team up through a license agreement to utilize innovative linker technology for developing advanced ADCs.
third-news.com
October 31, 2025 at 7:06 AM
Mycenax Biotech Partners with RIN to Enhance ADC Development Using Advanced Linker Technology#Taiwan#Taipei#ADC_Development#Mycenax_Biotech#RIN_Institute
Mycenax Biotech and SPERA PHARMA Forge Strategic Alliance for ADC Development#Taiwan#Taipei#ADC_Development#SPERA_PHARMA#Mycenax_Biotech
Mycenax Biotech and SPERA PHARMA Forge Strategic Alliance for ADC Development
Mycenax Biotech Inc. and SPERA PHARMA Inc. have joined forces to enhance the production services of antibody-drug conjugates, streamlining development for biopharmaceutical companies.
third-news.com
September 15, 2025 at 7:08 AM
Mycenax Biotech and SPERA PHARMA Forge Strategic Alliance for ADC Development#Taiwan#Taipei#ADC_Development#SPERA_PHARMA#Mycenax_Biotech
Mycenax and SPERA PHARMA Team Up to Revolutionize ADC Manufacturing Services#Taiwan#Taipei#ADC_Manufacturing#SPERA_PHARMA#Mycenax_Biotech
Mycenax and SPERA PHARMA Team Up to Revolutionize ADC Manufacturing Services
Mycenax Biotech and SPERA PHARMA announce an impactful partnership to enhance the manufacturing of ADC products, optimizing services for biopharmaceutical companies.
third-news.com
September 15, 2025 at 7:07 AM
Mycenax and SPERA PHARMA Team Up to Revolutionize ADC Manufacturing Services#Taiwan#Taipei#ADC_Manufacturing#SPERA_PHARMA#Mycenax_Biotech
Mycenax and SPERA PHARMA Join Forces to Enhance Pharmaceutical Manufacturing Services#Taiwan#Taipei#Pharmaceutical_Manufacturing#SPERA_PHARMA#Mycenax_Biotech
Mycenax and SPERA PHARMA Join Forces to Enhance Pharmaceutical Manufacturing Services
Mycenax Biotech Inc. and SPERA PHARMA have partnered to streamline biopharmaceutical manufacturing, focusing on conjugated antibody-drug services.
third-news.com
September 15, 2025 at 7:07 AM
Mycenax and SPERA PHARMA Join Forces to Enhance Pharmaceutical Manufacturing Services#Taiwan#Taipei#Pharmaceutical_Manufacturing#SPERA_PHARMA#Mycenax_Biotech
Mycenax and SPERA PHARMA Join Forces to Enhance ADC Manufacturing Services#Taiwan#Taipei#ADC_Manufacturing#Mycenax#SPERA_PHARMA
Mycenax and SPERA PHARMA Join Forces to Enhance ADC Manufacturing Services
Mycenax Biotech and SPERA PHARMA have formed a strategic alliance to optimize ADC production services, enhancing market readiness for global biopharma.
third-news.com
September 15, 2025 at 7:06 AM
Mycenax and SPERA PHARMA Join Forces to Enhance ADC Manufacturing Services#Taiwan#Taipei#ADC_Manufacturing#Mycenax#SPERA_PHARMA
Regeneron Pharmaceuticals Inc. v. SCD Biotech LLC et al: Discovery Application (Taiwan) https://www.offshorealert.com/regeneron-pharmaceuticals-inc-v-scd-biotech-llc-et-al-discovery-application-taiwan/ #offshorealert
Regeneron Pharmaceuticals Inc. v. SCD Biotech LLC et al: Discovery Application (Taiwan) - OffshoreAlert
Application from Regeneron Pharmaceuticals Inc. to take discovery from SCD Biotech LLC and SCD US Inc. for use in legal proceedings in Taiwan "involving Mycenax Biotech, Inc. and Adimmune Corporation", filed at the U.S. District Court for the District of Delaware.
www.offshorealert.com
March 8, 2026 at 3:32 PM
Regeneron Pharmaceuticals Inc. v. SCD Biotech LLC et al: Discovery Application (Taiwan) https://www.offshorealert.com/regeneron-pharmaceuticals-inc-v-scd-biotech-llc-et-al-discovery-application-taiwan/ #offshorealert
バイオシミラー市場の拡大に向けた新たな合弁会社設立の動き#アルフレッサ#カイオム#Mycenax
アルフレッサ、カイオム、Mycenax Biotechが共同出資し、バイオシミラーの製造を目指す新たな合弁会社を設立。国内製造能力の強化を目指します。
アルフレッサ、カイオム、Mycenax Biotechが共同出資し、バイオシミラーの製造を目指す新たな合弁会社を設立。国内製造能力の強化を目指します。
バイオシミラー市場の拡大に向けた新たな合弁会社設立の動き
アルフレッサ、カイオム、Mycenax Biotechが共同出資し、バイオシミラーの製造を目指す新たな合弁会社を設立。国内製造能力の強化を目指します。
news.3rd-in.co.jp
October 6, 2025 at 6:49 AM
